RVNC
Revance Therapeutics Inc
Price:  
2.80 
USD
Volume:  
1,458,811.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Relative Valuation

-1429.3%
Upside

As of 2024-06-18, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (37.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.80 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1429.3%.

The range of the Relative Valuation is (28.32) - (40.77) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 5.5x - 13.4x 9.1x
Forward P/E multiples 9.3x - 20.6x 15.4x
Fair Price (28.32) - (40.77) (37.22)
Upside -1111.3% - -1556.2% -1429.3%
2.80 USD
Stock Price
(37.22) USD
Fair Price

RVNC Relative Valuation - Historical P/E Data

Date P/E
2024-06-17 -0.92
2024-06-14 -0.93
2024-06-13 -0.98
2024-06-12 -1.00
2024-06-11 -0.97
2024-06-10 -0.90
2024-06-07 -0.89
2024-06-06 -0.95
2024-06-05 -1.00
2024-06-04 -0.96
2024-06-03 -0.99
2024-05-31 -0.93
2024-05-30 -0.95
2024-05-29 -0.92
2024-05-28 -0.88
2024-05-24 -0.89
2024-05-23 -0.88
2024-05-22 -0.96
2024-05-21 -0.99
2024-05-20 -1.04
2024-05-17 -0.99
2024-05-16 -1.04
2024-05-15 -1.09
2024-05-14 -1.15
2024-05-13 -1.09
2024-05-10 -1.09
2024-05-09 -1.41
2024-05-08 -1.41
2024-05-07 -1.44
2024-05-06 -1.35
2024-05-03 -1.30
2024-05-02 -1.24
2024-05-01 -1.25
2024-04-30 -1.19
2024-04-29 -1.21
2024-04-26 -1.12
2024-04-25 -1.08
2024-04-24 -1.17
2024-04-23 -1.20
2024-04-22 -1.20
2024-04-19 -1.24
2024-04-18 -1.25
2024-04-17 -1.24
2024-04-16 -1.25
2024-04-15 -1.31
2024-04-12 -1.36
2024-04-11 -1.46
2024-04-10 -1.45
2024-04-09 -1.54
2024-04-08 -1.46